Treatmentsa | ||||||
---|---|---|---|---|---|---|
OPAARMC | OPAA | LT1.3 | LT2.1 | LH3.0 | LV1.6 | |
Experiment, μg/mL | ||||||
Lys | 175 | 175 | 175 | 175 | 175 | 175 |
Met | 60 | 60 | 60 | 60 | 60 | 60 |
Lys/Met | 2.9:1 | 2.9:1 | 2.9:1 | 2.9:1 | 2.9:1 | 2.9:1 |
Thr | 97 | 97 | 135 | 83 | 97 | 97 |
Phe | 92 | 92 | 128 | 79 | 92 | 92 |
Thr/Phe | 1.05:1 | 1.05:1 | 1.05:1 | 1.05:1 | 1.05:1 | 1.05:1 |
Lys/Thr | 1.8:1 | 1.8:1 | 1.3:1 | 2.1:1 | 1.8:1 | 1.8:1 |
His | 74 | 74 | 74 | 74 | 57 | 74 |
Lys/His | 2.38:1 | 2.38:1 | 2.38:1 | 2.38:1 | 3.05:1b | 2.38:1 |
Val | 142 | 142 | 142 | 142 | 142 | 108 |
Lys/Val | 1.23:1 | 1.23:1 | 1.23:1 | 1.23:1 | 1.23:1 | 1.62:1c |
Rapamycin, ng/mL | 9.147 | - | - | - | - | - |
Other amino acids, μg/mL | ||||||
Arg | 84 | 84 | 84 | 84 | 84 | 84 |
Cys | 63 | 63 | 63 | 63 | 63 | 63 |
Gln | 584 | 584 | 584 | 584 | 584 | 584 |
Gly | 30 | 30 | 30 | 30 | 30 | 30 |
Ile | 105 | 105 | 105 | 105 | 105 | 105 |
Leu | 105 | 105 | 105 | 105 | 105 | 105 |
Ser | 42 | 42 | 42 | 42 | 42 | 42 |
Trp | 16 | 16 | 16 | 16 | 16 | 16 |
Tyr | 104 | 104 | 104 | 104 | 104 | 104 |